| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 面部埋植线(元) | 3,321,101.78 | 6,804,226.47 | 3,479,604.87 |
| 凝胶类注射产品(元) | 493,266,121.88 | 1,215,722,744.70 | 648,973,603.34 |
| 溶液类注射产品(元) | 744,000,729.46 | 1,743,949,380.33 | 976,281,612.43 |
| 冻干粉类注射产品(元) | 19,465,524.01 | - | - |
| 其他(元) | 39,129,009.13 | 59,192,097.97 | 28,175,141.77 |
| 营业成本(元) | |||
| 面部埋植线(元) | 658,187.28 | 1,053,278.24 | 555,422.43 |
| 凝胶类注射产品(元) | 11,121,498.51 | 24,575,944.29 | 13,131,244.80 |
| 溶液类注射产品(元) | 50,958,880.19 | 108,832,409.07 | 58,766,064.47 |
| 冻干粉类注射产品(元) | 4,868,016.60 | - | - |
| 其他(元) | 17,674,746.33 | 27,754,859.66 | 11,815,412.73 |
| 毛利(元) | |||
| 面部埋植线(元) | 2,662,914.50 | 5,750,948.23 | 2,924,182.44 |
| 凝胶类注射产品(元) | 482,144,623.37 | 1,191,146,800.41 | 635,842,358.54 |
| 溶液类注射产品(元) | 693,041,849.27 | 1,635,116,971.26 | 917,515,547.96 |
| 冻干粉类注射产品(元) | 14,597,507.41 | - | - |
| 其他(元) | 21,454,262.80 | 31,437,238.31 | 16,359,729.04 |
| 毛利率(%) | |||
| 面部埋植线(%) | 80.18 | 84.52 | 84.04 |
| 凝胶类注射产品(%) | 97.75 | 97.98 | 97.98 |
| 溶液类注射产品(%) | 93.15 | 93.76 | 93.98 |
| 冻干粉类注射产品(%) | 74.99 | - | - |
| 其他(%) | 54.83 | 53.11 | 58.06 |
| 收入构成(%) | |||
| 面部埋植线(%) | 0.26 | 0.22 | 0.21 |
| 凝胶类注射产品(%) | 37.97 | 40.18 | 39.17 |
| 溶液类注射产品(%) | 57.27 | 57.64 | 58.92 |
| 冻干粉类注射产品(%) | 1.50 | - | - |
| 其他(%) | 3.01 | 1.96 | 1.70 |
| 毛利构成(%) | |||
| 面部埋植线(%) | 0.22 | 0.20 | 0.19 |
| 凝胶类注射产品(%) | 39.72 | 41.60 | 40.43 |
| 溶液类注射产品(%) | 57.09 | 57.10 | 58.34 |
| 冻干粉类注射产品(%) | 1.20 | - | - |
| 其他(%) | 1.77 | 1.10 | 1.04 |